Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.3643
-0.0254 (-6.52%)
At close: Sep 1, 2026, 4:00 PM EDT
0.3754
+0.0111 (3.05%)
After-hours: Sep 1, 2026, 7:57 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $33.47 million as of September 1, 2026. Its market cap has decreased by -55.58% in one year.
Market Cap
33.47M
Enterprise Value
-9.27M
1-Year Change
-55.58%
Ranking
Category
Stock Price
$0.36
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $33.47M, a decrease of -34.41%. That is a compound annual growth rate of -8.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 33.47M | -75.22% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 40.32M |
| Actuate Therapeutics | 39.74M |
| CervoMed | 39.31M |
| TransCode Therapeutics | 36.91M |
| Quince Therapeutics | 34.33M |
| Veraxa Biotech AG | 34.04M |
| Lite Strategy | 33.36M |
| BriaCell Therapeutics | 32.50M |